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Abstract. Receptor tyrosine kinases play essential 
roles in morphogenesis and differentiation of epithelia. 
Here we examined various tyrosine kinase receptors, 
which are preferentially expressed in epithelia (c-met, 
c-ros, c-neu, and the keratin growth factor [KGF] re- 
ceptor), for their capacity to induce cell motility and 
branching morphogenesis of epithelial cells. We ex- 
changed the ligand-binding domain of these receptors 
by the ectodomain of trkA and could thus control sig- 
naling by the new ligand, NGF. We demonstrate here 
that the tyrosine kinases of c-met, c-ros, c-neu, the KGF 
receptor, and trkA, but not the insulin receptor, in- 
duced scattering and increased motility of kidney epi- 
thelial cells in tissue culture. Mutational analysis ug- 
gests that SHC binding is essential for scattering and 
increased cell motility induced by trkA. The induction 
of motility in epithelial cells is thus an important fea- 
ture of various receptor tyrosine kinases, which in vivo 
play a role in embryogenesis and metastasis. In con- 
trast, only the c-met receptor promoted branching mor- 
phogenesis of kidney epithelial ceils in three-dimen- 
sional matrices, which resemble the formation of 
tubular epithelia in development. Interestingly, the 
ability of c-met to induce morphogenesis could be 
transferred to trkA, when in a novel receptor hybrid 
COOH-terminal sequences of c-met (including Y14 to 
Y16) were fused to the trkA kinase domain. These data 
demonstrate hat tubulogenesis of epithelia is a re- 
stricted activity of tyrosine kinases, as yet only demon- 
strated for the c-met receptor. We predict he existence 
of specific substrates that mediate this morphogenesis 
signal. 
I 
N the last decade, a large variety of receptor tyrosine 
kinases were molecularly characterized (for reviews 
see Ultrich and Schlessinger, 1990; van der Geer et al., 
1994). Several of these receptors were first discovered be- 
cause of their transforming potential and were therefore 
associated with mediating mitogenic signals (Cooper et al., 
1984; Ullrich et al., 1984; Takahashi et al., 1985; Birchmeier 
et al., 1986). However, it has recently become evident 
that tyrosine kinase receptors can also regulate decisive 
events in development; i.e., these receptors control cell 
movement, morphogenesis, and differentiation (Montesano 
et al., 1991a,b; Peles et al., 1993; Schuchardt et al., 1994; 
Bladt et al., 1995, Cheng et al., 1995; Drescher et al., 1995; 
Meyer and Birchmeier, 1995; Werner et al., 1994; Yang et 
al., 1995; for a recent review see Birchmeier and Birch- 
meier, 1993). 
Previously, we and others have investigated the mor- 
phogenic activity of receptor tyrosine kinases on epithelial 
cells. It is noteworthy that several tyrosine kinase recep- 
tors exhibit exclusive or prevalent expression on epithelial 
cells. These include c-met, c-ret, c-ros, c-neu (c-erbB2), and 
the keratinocyte growth factor eceptor (KGFR) 1 (Miki et 
al., 1991; Sonnenberg et al., 1991, 1993; Peles et al., 1992; 
Schuchardt et al., 1994). The corresponding li ands, scat- 
ter factor/hepatocyte growth factor (SF/HGF), keratino- 
cyte growth factor (KGF), and neuregulin, were found to be 
preferentially synthesized by mesenchymal cells (Stoker 
et al., 1987; Sonnenberg et al., 1993; Rubin et al., 1989; 
Orr-Urtreger et al., 1993, Meyer and Birchmeier, 1995). 
SF/HGF has been described as a pleiotropic factor with 
various activities on epithelial cells in culture: (a) it pro- 
motes growth of primary hepatocytes and other epithelial 
cells (Miyazawa et al., 1989; Nakamura et al., 1989; Zarne- 
gar and Michalopoulos, 1989); (b) it can induce motility 
and invasiveness ofepithelial and endothelial cells (Stoker 
et al., 1987; Weidner et al., 1990; Bussolino et al., 1992; 
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Grant et al., 1993); and (c) it has a third and unusual activ- 
ity on epithelial cells, the ability to induce branching mor- 
phogenesis orthe formation of crypts in three-dimensional 
matrices (Montesano et al., 1991a,b; Berdichevsky et al., 
1994; Brinkmann et al., 1995; Soriano et al., 1995). SF/ 
HGF also controls branching morphogenesis of mouse 
mammary glands in organ culture and is expressed at ap- 
propriate times in the mammary gland during develop- 
ment (Yang et al., 1995). The various signals of SF/HGF 
are mediated by the c-met tyrosine kinase, as has been 
shown by the use of a hybrid receptor (Weidner et al., 
1993; cf. also Bottaro et al., 1991; Naldini et al., 1991; Ko- 
mada and Kitamura, 1993; Zhu et al., 1994). 
KGF was characterized asa growth factor for skin epi- 
thelial cells and is a member of the FGF family (Rubin et al., 
1989), which reacts with the FGF2-IIb receptor (Miki et al., 
1991). The c-neu (c-erbB2) receptor, together with two 
closely related molecules, c-erbB3 and c-erbB4, mediates 
the signaling of a recently described factor, neuregulin 
(Holmes et al., 1992; Wen et al., 1992; Carraway and Cant- 
ley, 1994). Neuregulin (also named neu differentiation fac- 
tor, heregulin, glial growth factor, or ARIA) is produced 
by mesenchymal and nerve cells (Orr-Urtreger et al., 1993; 
Meyer and Birchmeier, 1994) and acts on epithelial, mus- 
cle, and glial cells (Falls et al., 1993; Marchionni et al., 1993; 
Meyer and Birchmeier, 1995). Other epithelial receptor 
tyrosine kinases exist, to which no ligands were assigned 
yet, such as c-ros or c-ret (Riethmacher tal., 1994; Schu- 
chardt et al., 1994). 
The importance of receptor tyrosine kinases and their 
ligands in mesenchymal-epithelial interactions has recently 
been supported by genetic experiments. Targeted muta- 
tions in the SF/HGF and the c-met genes in mice lead to 
an identical phenotype, mbryonal lethality caused by se- 
vere deficiencies in the development of embryonal liver 
and placenta (Schmidt et al., 1995; Uehara et al., 1995). 
Furthermore, SF/HGF and c-met - / -  animals do not form 
particular muscles because of a defect in migration of myo- 
genic precursor cells from the somites to these target sites 
(Bladt et al., 1995). A dominant-negative KGF receptor 
under the control of the human lung surfactant protein C 
promoter induced severe defects in lung development (Pe- 
ters et al., 1994). This transdominant receptor also inter- 
fered with the development of the skin when expressed in
keratinocytes in vivo and prevented normal wound heal- 
ing (Werner et al., 1993, 1994). A targeted mutation in the 
c-ret gene of the mouse induced severe hypoplasia or apla- 
sia of the kidney and defects in development ofthe enteric 
nervous ystem (Schuchardt et al., 1994). Targeted muta- 
tion of the neuregulin, c-erbB2, and c-erbB4 genes in trans- 
genic mice leads to embryonal death at day 10 due to se- 
vere heart defects. In addition, cranial ganglia are absent, 
and the Schwann cell population in the trunk is greatly re- 
duced (Meyer and Birchmeier, 1995; Lee et al., 1995; Gass- 
mann et al., 1995). Targeted mutation of c-ros leads to 
male sterility due to abnormal development of epididymal 
epithelia (Riethmacher-Sonnenberg et al., 1996). 
A major question concerns the specific signal transduc- 
tion pathways involved in growth, morphogenesis, and dif- 
ferentiation ofepithelia that are mediated by tyrosine kinase 
receptors. Considerable vidence has been accumulated 
that relates to signal transduction by activated (oncogenic) 
tyrosine kinases. For instance, one of five COOH-terminal 
tyrosine residues of neu/erbB2 (Y1253) is responsible for 
transducing the mitogenic signal, a biochemical pathway 
that includes ras, mitogen-activated protein kinase, and 
transactivation f c-jun (Ben-Levy et al., 1994). In c-met, 
Y1354 (Y15), and to a lesser degree Y1347 (Y14), are in- 
volved in mitogenic signaling. These sites bind GRB-2, 
phospholipase C ~/(PLC~), c-src, and phosphatidylinositol 3 
(PI3) kinase and other substrates (Ponzetto et al., 1994; Fix- 
man et al., 1995). A c-ret pathway used in mitogenic signaling 
has also been characterized, and this activity is changed in 
germline mutations of MEN2A and MEN2B patients (San- 
toro et al., 1994; 1995). Ligand-dependent substrate activa- 
tion of receptor tyrosine kinases with morphogenic signals 
have also been studied: for instance, the COOH-terminal 
domain of let-23 (an EGF receptor homologue in Cae- 
norhabditis elegans) could be partitioned into subdomains 
with different cell type-specific functions (Aroian et al., 
1994). In the NGF receptor (trkA), mutation of Y490 (an 
SHC binding site) and a deletion of a conserved sequence 
in the juxtamembrane domain abolished NGF-induced 
neurite outgrowth in PC12 cells (Obermeier et al., 1994; 
Stephens et al., 1994; Peng et al., 1995). Ligand-induced 
dissociation and branching morphogenesis of c-met in epi- 
thelial cells were affected by mutation of Y1354 (Y15) and 
Y1363 (Y16) (Weidner et al., 1995). In the PDGF[3 recep- 
tor, the kinase insert contains the structural requirements 
for the motility response in endothelial cells (Wennstr6m 
et al., 1994), which are binding sites for PI3 kinase (Fantl 
et al., 1992; Kashishian et al., 1992). Neurite outgrowth of 
PC12 cells could also be induced by the PDGFI3 receptor; 
here, PI3 kinase and PLC~/ are involved (Vetter and 
Bishop, 1995). 
In the present investigation, we have analyzed the po- 
tential of several epithelial receptor tyrosine kinases to in- 
duce motility and morphogenic signals in MDCK epithelial 
cells. We found that the signal for branching morphogene- 
sis of kidney epithelial cells is specific for c-met, whereas 
dissociation and increased motility can be transmitted by 
several tyrosine kinase receptors. A morphogenic signal 
could be created by fusing the COOH-terminal tail of c-met 
to the kinase domain of the trkA receptor, indicating that 
Y14 to Y16 of c-met are critical in mediating a signal that 
induces morphogenesis. 
Materials and Methods 
Construction and Expression of the trkA 
Receptor Hybrids 
The trkA-cDNA (encoding the human NGF receptor, plasmid pLM6) was 
obtained from Dr. L. Parada (National Cancer Institute, Frederick, MD). 
The cDNAs of the human insulin receptor (IR) as well as the trk-Y751F 
and trk-Y785F hybrids (plasmids pINS3, pCMV-ET-Y751F, and pCMV- 
ET-Y785F) were as described (Obermeier et al., 1993). The cDNAs of the 
murine c-ros tyrosine kinase (plasmid pMR1N), the rat c-neu proto-onco- 
gene (pSVneuN), and the mouse keratinocyte growth factor receptor (plas- 
mid KGFR-pCEV27) were provided by Dr. C. Birchmeier (MDC, Berlin, 
Germany), Dr. M.F. Rajewsky (Institute of Cell Biology, Essen, Germany), 
and Dr. S.A. Aaronson (National Institutes of Health, Bethesda, MD), re- 
spectively. The construction of the trk-met hybrid is described in Weidner 
et al. (1993). 
The cDNA fragments for the construction of the trk-ros hybrid recep- 
tor were generated as follows: fragment I encoding the extracellular por- 
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tion of trkA (pLM6) with an XbaI and an NheI site at the 3'-end was di- 
gested with XbaI, blunt ended with Mung bean uclease, and digested 
with NheI. This fragment was ligated with fragment II encoding the trans- 
membranous and the cytoplasmic portion of c-ros. Fragment II was made 
in two steps: (a) PCR with the primers 5'-ATAACAGAAACAGAAT- 
TCATACTrACTATCATAGTT and 5'-CCITCAGGAACTCAATCTr- 
CTCC and pMR1N as template was used to generate an internal EcoRI 
site at the 5'-end of the transmembranous region of c-ros. (b) This frag- 
ment was fused to the COOH-terminal part of c-ros using an internal 
AvrlI site. For in-frame fusion with fragment I, the EcoRI site in fragment 
II was partially fiiled with dATP, blunt ended with Mung bean nuclease, 
and ligated as NheI fragment. 
For construction of the trk-neu hybrid, a COOH-terminal fragment of 
the extraceUular part of trkA and the transmembrane and cytoplasmic part 
of c-neu was amplified with the primers 5'-GGTCCAGGTGCCCAATG- 
CCTCGG (W3), 5'-AATGATGAATGT/TCGTCCYFCTrCTCCACCG, 
5'-CGGTGGAGAAGAAGGACGAAACATTCATCATT, and 5'-GGT- 
GGTGGTGACTAGTTCATACAGGTACATCCAG (S1), respectively. 
The resulting fragments were purified, mixed, and used as templates for a 
second PCR with the primers W3 and S1. The generated chimeric frag- 
ment was digested with BamHI and SpeI, purified, and ligated into a mod- 
ified pUCll8 vector with MscI and SpeI sites. Ligation with a NH2-termi- 
nal KpnI-BamHI fragment of trkA resulted in the full-length ybrid. 
For trk-KGFR, the primers W3, 5'-GCAGTAAATAGCTATVI'CGTC- 
CTFCITCTCCACCG, 5 '-AAGAAGGACGAAATAGCTATITACTG- 
CATAGGG, and 5'-GTGGTGGTGTCTAGA'I'FATGTYI-TAACAC- 
TGCCG were used with the templates pLM6 and KGFR-pCEV27. The 
amplified fusion fragmem was digested with BamHI and XbaI and ligated 
with the NH2-terminal EcoRI-BamHI fragment of trkA. The trk-IR hy- 
brid and the trk-Y490F mutant were made using a similar strategy: for the 
trk-IR hybrid, the primers W3, 5'-GGGGCCGATGATAATITCGTC- 
CTTCTI'CTCCAC, 5'-AAGAAGGACGAAATTATCATCGGCCCC- 
CTCATCL and 5'-GTGGTGGTCGACITAGGAAGGATTGGAC(X3- 
AGG were used. The amplified trk-IR fusion fragment was digested with 
BamHI-SalI, purified, and ligated into pUCll8. The NH2-terminal KpnI- 
BamHI fragment of trkA was ligated into this plasmid and resulted in the 
full-length trk-IR hybrid. For the trk-Y490F mutant, primers W3, 5'-CA- 
CAGGCATCACTGAAGAAT]?GTGGGTI'CT, 5'-ATCGAGAACCCA- 
CAATrCITCAGTGATGCCTGTG ($2), and 5'-CACCAGTCCCTG- 
GCCCACTAGAC were used with pLM6 as template. An internal Barn 
HI-NheI fragment containing the Y490 codon in trkA was replaced by the 
fragment containing the Y490F mutation. For constructing trk-Y751F and 
trk-Y785F, the internal NheI site in the trkA cDNA and the plasmids 
pCMV-ET751F and pCMV-ET-785F were used to mutate the wild-type 
codons Y751 and Y785. An NheI site at the 3'-end of the cDNAs of trkA, 
trk-Y751F, and trk-Y785F was introduced by ligation with an NheI linker. 
The NheI fragment of the trkA was then replaced by the corresponding 
fragments of the mutated trkA hybrids. For constructing the two trkA 
receptors containing the COOH-terminal tail of c-met, the primers $2, 
5'-GGAGAAGATTGAGGACAGCCGGGCGTGCACATCC, 5'-TGTG- 
CACGCCCGGCTGTCCTCAATCTTCTCCACG, and 5'-GAGGACA- 
CTAGTGCTAGCTCATGTGTrCCCCTCGCCATC with the templates 
pLM6 and the trk-met hybrid were used. After amplification of the trk-met 
fusion fragment, he tail of trkA could be replaced by the c-met ail from 
the corresponding trk-met hybrid. 
The correct sequences of the hybrid and mutant receptor cDNAs were 
confirmed by sequencing using T7 DNA polymerase (Pharmacia, Upp- 
sala, Sweden). The hybrid receptor cDNAs were cloned into the pBAT 
expression vector (Nagafuchi and Takeichi, 1988) and stably introduced 
into MDCK epithelial cells by calcium phosphate eotransfection (Graham 
and van der Eb, 1973) with pSV2neo. G418-resistant cell clones were as- 
sayed for NGF-induced cell dissociation, branching morphogenesis, and 
expression of the various receptors. 
Assays for Cell Motility and Morphogenesis 
Dissociation and motility of MDCK cells were examined in a colony disso- 
ciation assay (Stoker et al., 1987; Weidner et al., 1990) in the presence or 
absence of the indicated concentrations of SF/HGF or NGF, (2.5 S; Boeh- 
ringer Mannheim GmbH, Mannheim, Germany). Recombinant SF/HGF 
was expressed in Sf9 insect cells and purified as described (Weidner et al., 
1993). Photomicrographs of the cells were taken after 24 h with a phase 
contrast microscope (Zeiss, Oberkochen, Germany). Branching morpho- 
genesis of MDCK cells was analyzed as described (Montesano et al., 1991b; 
Weidner et al., 1993) with modifications: collagen gels were prepared at 
4°C as 1:1 solutions of collagen R (2 mg/ml; Serva Feinbiochemica GmbH, 
Heidelberg, Germany) and collagen G (3 mg/ml; Seromed, Heidelberg, 
Germany) containing DME, 10% FCS, and 2.2 mg/ml NaHCO3. In earlier 
studies, we have used only collagen G (cf. Brinkmann et al., 1995). Since 
the optical quality of new batches of collagen G were recently different, 
we included collagen R (which is optically clear, but alone does not pro- 
mote growth and morphogenesis). The mixture was neutralized with 1 N 
NaOH, and 500 I~1 were plated per well in a 12-well tissue-culture plate 
(Nunc, Roskilde, Denmark) and gelized at 3TC for 30 min. Nearly confluent 
MDCK cells were trypsinized to a stage of small aggregates, and aggre- 
gates containing 104 cells were plated in a second layer of 500 ixl collagen 
solution. After 30 min at 37°C, the gels were covered with 2 ml ceil culture 
medium and incubated overnight at 37°C and 5% CO2. The next day, me- 
dium was changed, factors were added (50 ng/ml SF/HGF, 400 ng/ml 
NGF), and the cultures were inspected aily. Photomicrographs were 
taken with a light microscope (Zeiss) equipped with Nomarski interfer- 
ence optics. For fine structure analysis, collagen cultures were fixed with 
Figure 1. Structure of various hybrid tyrosine kinase receptors. (a) The ectodomain of t rkA is fused to the t ransmembrane and cytoplas- 
mic domains of c-met, c-neu, c-ros, the KGFR,  and the IR, respectively. Ellipses, cysteine residues in the ectodomain; boxes, location of 
the tyrosine kinase domains within the cytoplasmic part. (b) Nucleotide and amino acid sequences of the fusion points between the ex- 
tracellular and the t ransmembrane r gion (underlined, hydrophil ic sequence of the trkA ectodomain; bold type, adjacent ransmem- 
brane region of the various fused receptors). For construction of the receptors, see Materials and Methods.  
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Figure 2. Effect of various hybrid receptors on the cellular phenotype of MDCK epithelial cells in culture. The hybrid receptors trk- 
met, trk-neu (c-erbB2), trk-ros, and trk-KGFR induced NGF-dependent scattering of the cells (middle column), as did SF/HGF (right 
column). The concentrations of NGF and SF/HGF were 50 ng/ml. Control, untreated cells (left column). Cell morphology was analyzed 
after 24 h. Bar, 20/~m. For the efficiency of successful transfections, see Table I. 
2.5% glutaraldehyde (Sigma, Deisenhofen, Germany), and small blocks 
containing representative cell aggregates w re cut from the gel. After 
postfixation with OSO4, the blocks were contrasted with tannic acid and 
uranyl acetate. The specimens were dehydrated in a graded ethanol series 
and embedded in Epon 812. Ultrathin sections (50-70 nm) were con- 
trasted with lead citrate and analyzed in an electron microscope (EM 10; 
Zeiss). Semithin sections (0.5I~m) were stained with toluidine blue and 
analyzed with a light microscope (Axiophot; Zeiss). 
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Immunoprecipitation and Western Blotting 
For examining tyrosine autophosphorylation of the various tyrosine ki- 
nase hybrids, 5 × 106 MDCK cells were incubated for 10 rain at 37°C in 
the presence or absence of NGF (50 ng/ml) in DME, 0.5% BSA, 7 ~xM 
phenyl arsine oxide, washed with PBS, and extracted for 1 h at 4°C with 
RIPA-kinase lysis buffer (Weidner et al., 1993). After clearing by ultra- 
centrifugation at 100,000 g, immunoprecipitation was carried out using 
protein A-Sepharose (Pharmacia) and a 1:200 dilution of polyclonal anti- 
sera directed against he COOH terminus of mouse c-met, human c-neu, 
human trkA (Santa Cruz Biotechnology Inc., Santa Cruz, CA), human IR 
(Transduction Laboratories, Lexington, KY), and mouse c-ros (kindly 
provided by Dr. C. Birchmeier). After washing with RIPA-kinase lysis 
buffer and high salt buffer, the immunoprecipitates w re separated by 6% 
SDS-PAGE. The proteins were transferred to nitrocellulose membranes 
(Amersham Intl., Little Chalfont, UK), probed with antiphosphotyrosine 
mAb PY-20 (Upstate Biotechnology Inc. [UBI], Lake Placid, NY), and 
stained using the enhanced chemiluminescence system (ECL; Amersham 
Intl.). Alternatively, the various receptors were immunoprecipitated with 
the mAb TTM-9.9.2 directed against he NI-I 2 terminus of human trkA 
(kindly provided by Dr. M. Barbacid, Bristol-Meyers-Squibb Princeton, 
N J). 
Results 
Construction and Biological Activities 
of Chimeras between the NGF Receptor (trkA) and 
Various Epithelial-specific Tyrosine Kinases 
We have previously shown that a chimeric receptor contain- 
ing the extracellular sequences ofthe NGF receptor and the 
transmembrane and cytoplasmic sequences of c-met rans- 
mits c-met-specific signals in the presence of NGF (Weid- 
ner et al., 1993). Here we have constructed a series of hy- 
brids of trkA and the kinase domains of c-neu (c-erbB2), 
c-ros, KGFR, and IR (Fig. 1 a). In all, the first hydropho- 
bic amino acid of the transmembrane domain of the recep- 
tors was fused in frame to the sequences encoding the last 
(acidic) amino acid of the extracetlular sequence of trkA 
(Fig. 1 b). The hybrid cDNAs were cotransfected with a 
neomycin resistance gene into MDCK cells; for each cDNA 
transfection 30-70 independent G418-resistant clones were 
analyzed for biological activities and then for expression 
of the receptors. Wild-type trkA was also examined. 
Table L Stable Transfectants ofMDCK Cells with Hybrid 
Receptor Tyrosine Kinases as Analyzed for NGF-dependent 
Scattering 
Hybrid receptors Cell scattering 
Responding clones~total % 
trk-met 17/48 35 
trk-neu 12/34 35 
trk-ros 16/68 24 
trk-KGFR 23/60 38 
trk-lR 0/60 0 
trkA 17/71 24 
trk-Y490F (SHC) 0/44 0 
trk-Y751F (PI3K) 18/56 32 
trk-Y785F (PLC~/) 9/44 20 
trk-Y14-16 of met 24/56 43 
trk-Y490F-Y 14-16 of met 0/81 0 
trk-Y 15F of met 8/61 13 
trk-Yl6F of met 10/72 14 
trk-Y14/16F of met 10/62 16 
trk-Yl4/15F of met 13/68 19 
MDCK cell clones that express the various hybrid recep- 
tors were first examined for NGF-induced cell dissociation 
(Fig. 2; Table I and II). We found that the chimeric -met, 
c-neu, c-ros, and KGF receptors induced dissociation and 
scattering of the cells in the presence of NGF (Fig. 2, mid- 
dle column). 20-40% of the G418-resistant clones were re- 
sponsive to NGF, which is similar as previously reported 
with trk-met (Table I; cf. also Weidner et al., 1993). The cells 
transfected with different chimeric receptors were also reac- 
tive to SF/HGF (Fig. 2, right column). Cells transfected with 
the trk-IR construct were not dissociated by NGF (Table 
II). However, our trk-IR hybrid was active in other ceils 
(Isakoff et al., 1995). We should also note that neuregulin, 
the ligand of c-erbB3 and c-erbB4, which are coreceptors 
of c-neu (c-erbB2) (Karuagaran et al., 1996; Carraway and 
Cantley, 1994), does not scatter MDCK epithelial cells. 
Also, acidic FGF that binds to the KGF receptor (Miki et 
al., 1991) does not dissociate the cells (data not shown). 
We have not examined MDCK cells for the expression of 
these receptors. 
Surprisingly, the transfected wild-type trkA receptor also 
dissociated MDCK epithelial cells in the presence of NGF 
(Fig. 3). This finding allowed us to examine the substrate 
requirements for dissociation of MDCK cells since trkA 
with mutated substrate binding sites have been described: 
Y490, Y751, and Y785 of trkA are binding sites for SHC, 
PI3 kinase, and PLC% respectively (Obermeier et al., 
1994). We found that loss of SHC binding of trkA due to 
mutation of tyrosine 490 to phenylalanine prevented NGF- 
induced cell dissociation (Fig. 3; and Table II). The cells 
were still reactive to SF/HGF. Mutations of the other two 
tyrosine residues of trkA, Y751 and Y785, had no inhibi- 
tory effect. Thus, signals mediated by various receptor ty- 
Table II. Biological Effects of Various Hybrid Receptors on 
MDCK Cells 
Hybrid receptors Dissociation, motility Branching morphogenesis 
trk-met + + 
trk-neu + - 
trk-ros + - 
trk-KGFR + - 
trk-IR - - 
trkA + 
trk-Y490F (SHC) 
trk-Y751F (PI3K) + 
trk-Y785F (PLC3') + 
trk-met + + 
trk-met Y 14F + + 
trk-met Y15F + $* 
trk-met Y 16F + ,I, 
trk-met Y 15F/Y 16F + ,I, 
trk-met Y 14F/Y 16F + ,[, 
trk-met YI4F/Y15F $ - 
trk- Y14-16 of met + + 
trk- Y490F-YI4-16 of met - - 
trk-Y15F of met + - 
trk-Y16F of met + - 
trk-Y14/16F of met + - 
trk-Y14/15F of met + - 
*The downward pointing arrow indicates rethx:ec~ biological activity (cf. Weidner el 
al:, 1995). 
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Figure 3. Effect of various Y --~ F mutants of trkA on the phenotype of MDCK epithelial cells. The Y751F and Y785F mutants of trkA 
induced NGF-dependent scattering of the cells in a similar manner as the wild-type trkA receptor. In contrast, he Y490F mutation in the 
trkA receptor abolished NGF-dependent scattering of the cells. MDCK cells were cultured with NGF (50 ng/ml), SF/HGF (50 ng/ml), or 
without factor (control). Cell morphology was analyzed after 24 h. Bar, 20 ixm. For efficiency of successful transfection, see Table I. 
rosine kinases can scatter kidney epithelial cells. In addi- 
tion, binding of a particular substrate, SI-IC, appears to be 
necessary fo r mediat ing this motil ity response. 
We also examined the expression and aut0phosphoryla- 
tion levels of the various hybrid tyrosine kinase receptors 
in the NGF-responding cell clones (Fig. 4). We found that 
tyrosine phosphorylation f c-met, c-neu, c-ros, and the IR 
was clearly dependent on the presence of NGF (cf. arrows 
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Figure 4. NGF-dependent tyrosine phosphorylation of the various trkA hybrids and mutants. Transfectants of MDCK cells expressing 
various hybrid receptors (a) and trkA mutants (b) were analyzed for NGF-dependent tyrosine phosphorylation of the receptors. Recep- 
tors were immunoprecipitated with the corresponding antisera directed against the COOH termini of the kinases and Western blotted 
using an antiphosphotyrosine antibody (cf. Materials and Methods). (Arrows) Receptors phosphorylated in response to NGF. 
in Fig. 4 a). All hybrid receptors had the xpected molecu- 
lar mass, i.e., trk-met, 145 kD; trk-ros, 151 kD; trk-neu, 
165 kD; and trk-IR, 144 kD. Wild-type trkA and its mu- 
tants showed identical molecular masses of 140 kD (Fig. 4 
b). In general, the clones transfected with one particular 
hybrid cDNA and selected for NGF-induced scattering ex- 
pressed similar amounts of receptor molecules and showed 
similar levels of receptor phosphorylation (cf. c-neu and 
c-ros in Fig. 4 a). Immunoprecipitations of the hybrid re- 
ceptors with an mAb against he NH2 terminus of trkA 
also showed similar amounts of reacting protein (data not 
shown). Wild-type and mutant rkA receptors were also 
expressed and phosphorylated at similar levels in various 
cell clones (Fig. 4 b). We have also examined other recep- 
tor chimeras uch as trk-ret and trk-ddr (the discoidin do- 
main receptor) (cf. Johnson et al., 1993; Lai and Lemke, 
1994; Alves et al., 1995); these receptors were expressed in
MDCK cells, but did not display NGF-dependent tyrosine 
phosphorylation, and were therefore not used for further 
experiments. 
The Specificity of c-met for Branching Morphogenesis 
Branching morphogenesis of the various MDCK cell trans- 
fectants, which responded to NGF by cell scattering, was 
examined by culturing the cells in three-dimensional gels 
of collagen type I (cf. Materials and Methods). In the ab- 
sence of ligand, the cells formed slowly growing, hollow 
cysts (Fig. 5, left column). We observed that only the trans- 
fected trk-met hybrid, but not rk-ros, trk-neu, and wild- 
type trkA, induced branching morphogenesis in response 
to NGF (Fig. 5, middle column; cf. also Table II). The trk- 
met hybrid also clearly promoted proliferation of the cells 
in collagen; we have here not quantified this activity (cf. 
Weidner et al., 1993). Again, all transfected cell clones re- 
sponded with branching morphogenesis in the presence of 
SF/HGF, indicating that the signaling capacity for branch- 
ing morphogenesis was intact (Fig. 5, right column). The 
trk-KGFR and trk-IR hybrids did also not induce NGF- 
dependent branching (Table II). 
Previous results of our laboratory have indicated that 
mutations of Y15 (Y1354), Y16 (Y1363), and, to a lesser 
degree, Y14 (Y1347) of c-met lead to the disturbance of 
branching morphogenesis of MDCK cells (Weidner et al., 
1995; cf. Table II). Here, we attempted tocreate a trkA re- 
ceptor with the ability to induce branching morphogenesis; 
to do this we fused to it the COOH-terminal sequence of 
c-met encoding Y14-16 (Fig. 6, c.f. Materials and Meth- 
ods). This new receptor chimera (trk-Y14-16 of met) in- 
deed induced scattering and, surprisingly, also morpho- 
genesis of MDCK cells in the presence of NGF (Fig. 7; 
Table II). Detailed inspection indicated that the tubules 
induced by the chimeric receptor are identical to the ones 
formed in the presence of SF/HGF (compare Fig. 7, b and 
c). Analysis of tissue sections showed that the NGF- 
induced branches consist of single layers of cells surrounding 
a central lumen. The cells of the tubules are well polarized, 
showing basally ocalized nuclei and apical microvilli (Fig. 
7, d and e). This new trk-met receptor did not induce scat- 
tering and morphogenesis when Y490 of trkA was mu- 
tated (Table II). Mutation of Y15 (Y1354) or Y16 (Y1363) 
of the tail of c-met in the new trk-met receptor abolished 
morphogenesis but not scattering. The data thus demon- 
strate that the novel combination of the trkA tyrosine ki- 
nase domain linked with COOH-terminal sequences of 
c-met is sufficient o induce a morphogenic response when 
activated by the ligand. 
Discussion 
Developmental studies have indicated that various recep- 
tor tyrosine kinases can mediate different signals in epi- 
thelia. Here we have analyzed various epithelial receptor 
tyrosine kinases for their potential to induce biological re- 
sponses in kidney epithelial cells, such as the ability to 
form branching tubules or to induce cell scattering and in- 
creased cell motility. Branching morphogenesis is particu- 
larly relevant in the development of many epithelial organs, 
which occurs in kidney, lung, breast, prostate, or salivary 
gland. Interestingly, we found that the tyrosine kinase 
c-met, which is the receptor for SF/HGF, induces tubule 
formation and branching of kidney epithelial cells exclu- 
sively. Various other tyrosine kinase receptors such as c-neu, 
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Figure 5. Effect of various hybrid receptors on NGF-induced branching morphogenesis of MDCK cells in collagen gels. Only the trk- 
met receptor conferred NGF-dependent branching morphogenesis in a similar manner as activation of the endogenous c-met receptor 
by SF/HGF. MDCK cell clones were precultured in collagen gels (cf. Materials and Methods), incubated with NGF (400 ng/ml), SF/ 
HGF (50 ng/ml), or without factor (control), and analyzed for branching morphogenesis. Bar, 180 i~m. 
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Figure 6. Structure of the trkA hybrid with the 
COOH terminus of c-met. The region surround- 
ing the fusion point is enlarged below; it shows 
the COOH-terminal leucine (L) of the trkA ki- 
nase domain, which is fused to the c-met tail 
(bold type) containing Y14 (Y1347), Y15 (Y1354), 
and YI6 (Y1363). Y14 (Y1347) of c-met is dashed 
in the enlargement. 
c-ros, the KGFR, or trkA did not display this activity but 
were able to dissociate and to scatter epithelial cells. This 
latter is a surprising result, since scattering was thought o 
be specific for SF/HGF in these cells. Only one other pro- 
tein, "scatter factor-like factor" has been shown to dissoci- 
ate MDCK cells (Bellusci et al., 1994a). Interestingly, the 
ability to form branching tubules could be newly created 
when the COOH terminus of c-met (which contains the 
major substrate binding sites) was fused to the COOH ter- 
minus of the kinase domain of trkA. Thus, the COOH-ter-  
minal part of c-met mediates the signals required for the 
formation of branched tubules in kidney cells and may 
bind novel, as yet unidentified substrates. 
We have previously demonstrated that the two func- 
tions, scattering and morphogenesis of epithelial cells, can 
be induced by separate means: the two-kringle variant of 
SF/HGF, which is a small splice form containing only the 
NH2-terminal hairpin structure and the first two-kringle 
Figure Z Effect of trkA with the COOH-terminal tail of c-met on NGF-induced branching morphogenesis of MDCK cells in collagen 
gels. Branching morphogenesis was induced with NGF (b; 400 ng/ml) and SF/HGF (c; 50 ng/ml); a is the control without factors. Branch- 
ing structures were sectioned and inspected by light (d) and electron microscopy (e). lu, lumen of branched structures; co, collagen ma- 
trix. Bars: (a--c) 184 ~m; (d) 33 Ixm; and (e) 3 ~m. 
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Figure 8. Scheme of the different modules in trkA and c-met re- 
quired for scattering and branching morphogenesis. In the recep- 
tor chimera trk-Y14-16 of met (middle), the ligand-binding re- 
gion, the juxtamembrane region including the SHC binding site 
for motility (Y490), plus the kinase domain originate from trkA. 
The COOH terminus (black bar) containing Y14 (1347), Y15 
(Y1354), and Y16 (Y1363) is from c-met and promotes branching 
morphogenesis. 
domains, promoted only dissociation of the cells but not 
the formation of branched tubules or growth (Hartmann 
et al., 1992; data not shown). Here we were now able to 
separate these two distinct pathways on the receptor level 
(Fig. 8). We found that several receptor tyrosine kinases 
can scatter epithelial cells, and we have previously re- 
ported that v-src (expressed as a temperature-sensitive 
mutant) also leads to scattering of MDCK cells (Behrens 
et al., 1993). It appears that the action of the substrate 
SHC is essential for this response: mutation of the SHC 
binding site Y490 in trkA, but not mutation of the binding 
sites for PI3 kinase or PLC~/(Y751 and Y785) (cf. Ober- 
meier et al., 1994), abolished scattering. In c-met, double 
mutation of the potential SHC binding sites Y14 and Y15 
(Y1347 and Y1354) (cf. Ponzetto et al., 1994) also prevented 
the scattering response (Weidner et al., 1995). Accord- 
ingly, overexpression f SHC in fibroblasts increased cell 
motility (Pelicci et al., 1995). Furthermore, the ras path- 
way in epithelial cells is required for the motility response 
induced by SF/HGF, since the dominant-negative ras-Nl7 
mutant interfered (Hartmann et al., 1994; cf. Ridley et al., 
1995). Thus, cell dissociation and scattering of epithelial 
cells appears to require activation of SHC and possibly re- 
cruitment of GRB-2 (cf. Rozakis-Adcock et al., 1992, 1993; 
Egan et al., 1993; Pawson and Schlessinger, 1993) that acti- 
vate the ras pathway. We must also assume that the motil- 
ity response of trkA and c-met induced by SHC requires 
binding through the PTB (PI) and SH2 domains, respec- 
tively (Kavanaugh and Williams, 1994; Blaikie et al., 1994; 
Gustafson et al., 1995; Pelicci et al., 1995; Zhou et al., 
1995). 
Recently, the importance of the SF/HGF/c-met system 
in cell motility in vivo was clearly demonstrated by gene 
ablation experiments in mice (Bladt et al., 1995). Myoblast 
precursor cells, which derive from epithelioid somites and 
express c-met, cannot migrate into SF/HGF expressing 
limb buds and other targets in both SF/HGF and c-met - / -  
embryos. Cell migration induced by SF/HGF also plays a 
crucial role in invasion and metastasis (Weidner et al., 
1990; Bellusci et al., 1994b; Rosen et al., 1994). It has re- 
cently been shown that SF/HGF is expressed in human 
breast cartcinomas nd that the level of expression correlates 
with the state of tumor progression (Yamashita et al., 1994). 
We also show here that only the c-met receptor, but not 
other tyrosine kinases, induces tubule formation of kidney 
epithelial cells. Mutation of Y15 (Y1354) and Y16 (Y1363), 
and to a lesser degree Y14 (Y1347), reduced this activity 
(cf. Weidner et al., 1995). The requirement for signals that 
induce branched tubules was further studied using a newly 
created hybrid between the kinase domain trkA (which 
induces only scattering) and the substrate binding sites 
Y14-16 of c-met (which can confer branching morphogen- 
esis) (Fig. 8). It is known that Y14 and Y15 of c-met repre- 
sent a tandem binding site for many substrates such as PI3 
kinase, PLC~/, rasGAP, c-src, and others (Ponzetto et al., 
1994). However, these substrates can also bind to other re- 
ceptor tyrosine kinases that confer only scattering; for in- 
stance, trkA has binding sites for SHC, PI3 kinase, and 
PLC'y (Obermeier et al., 1994); c-neu (c-erbB2) has puta- 
tive binding sites for rasGAP, PLC% syp, GRB-2, and 
SHC (Segatto et al., 1993; Carraway and Cantley, 1994; 
Ricci et al., 1995). It is therefore suggested that tubule for- 
mation of epithelial cells induced by c-met requires the ac- 
tivation of additional, as yet unknown substrates. The se- 
quence flanking Y16 (Y1363, VAPYPSLL), which affects 
morphogenesis (Weidner et al., 1995), has in fact an un- 
usual sequence and might represent a new substrate bind- 
ing site. We have recently begun a search for new sub- 
strates that may mediate the morphogenesis response of 
c-met by using the yeast wo-hybrid system (cf. Gustafson 
et al., 1995; Waters et al., 1995) and have identified sub- 
strates that bind specifically to c-met (Weidner, K.M., M. 
Sachs, S. DiCesare, and W. Birchmeier, manuscript in 
preparation). Alternatively, cell motility and branching 
morphogenesis might be due to differences in signal inten- 
sity and/or signal persistence ("shouting vs whispering") 
(cf. Dikic et al., 1994; Traverse et al., 1994; Marshall, 
1995). For instance, strong signaling might be required for 
scattering followed by reduced activity during reformation 
of the epithelial structures. Alternatively, morphogenesis 
might require stronger signaling than scattering. Our 
present work has demonstrated, however, that branching 
morphogenesis byc-met does not require Y1001. This ty- 
rosine residue in the juxtamembrane region of c-met nega- 
tively regulates the receptor activity; its mutation leads to 
constitutive scattering and fibroblastoid morphology of 
epithelial cells (Weidner et al., 1995). In conclusion, we 
suggest here that scattering of epithelial cells requires the 
action of the substrate SHC, whereas new, as yet unidenti- 
fied substrates induce branching morphogenesis. 
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Interestingly, we could transfer signaling specificity of 
c-met, i.e., particularly the unique activity of the receptor to 
induce formation of branching tubules, upon the trkA recep- 
tor by transferring COOH-terminal sequences of c-met 
that are active in substrate binding. Exchanges of sequences 
in receptor tyrosine kinases were previously reported for 
the kinase insert domains of PDGFot and 13 receptors 
(Arvidsson et al., 1992) and PDGFI3 and FGF receptors 
(Wennstr6m et al., 1994). It was thus possible to transfer 
the activity of membrane ruffling upon the new receptors. 
Our exchange involved distantly related tyrosine kinases 
and an element (the COOH terminus of c-met) that is struc- 
turally entirely different from the corresponding element 
in trkA. This new finding is again a strong indication of a 
modular arrangement of the elements in tyrosine kinases, 
i.e., the kinase domain, on the one hand, and various sub- 
strate binding regions with multiple functions on the other. 
The recent gene ablation experiments of SF/HGF and 
c-met in mice have revealed an important role of this sig- 
naling system in epithelial development (Schmidt et al., 
1995; Uehara et al., 1995). Embryonic liver and placenta 
are affected in these mutants. A function of SF/HGF in the 
development of epithelia has also been demonstrated by 
organ culture experiments with kidney and mammary gland 
explants (Woolf et al., 1995; Yang et al., 1995). We have 
recently also shown that SF/HGF, besides controling branch- 
ing of kidney, breast, and prostate epithelia cells, induces 
further characteristic epithelial organoids uch as crypts and 
alveoli (Brinkmann et al., 1995). Considering the relevance 
of morphogenesis of epithelia for the development of many 
eukaryotic organs, the identification of specific substrates 
that control these processes in vivo will therefore be an 
important task in the future. 
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